Simon Shavanson
On June 12, 2024, Yangyang Huang and Simon Shavanson (collectively the “Resigning Directors”) resigned from the Board of Directors of Bio Essence Corp. (the “Company”).
Highest-materiality recent filing
Acquired MediFlow AI (formerly AcuVital) from Zhituo Software for $3,500,000 in restricted common stock.
Bio Essence acquires MediFlow AI software for $3.5M in restricted stock
Bio Essence (BIOE) entered an Asset Purchase Agreement to buy the MediFlow AI (formerly AcuVital) platform from Zhituo Software.
Bio Essence Corp. restates Q1 2024 financials due to unapproved lease termination accounting error
Determined on Aug 19, 2024 that financial statements for Q1 ended March 31, 2024 cannot be relied upon.
Bio Essence dismisses auditor Keith K. Zhen, CPA, appoints Simon & Edward, LLP effective Aug 1, 2024
Dismissed prior independent accountant Keith K. Zhen, CPA on August 1, 2024.
Bio Essence Corp. dismisses auditor Keith K. Zhen, CPA; appoints Simon & Edward, LLP
Dismissed Keith K. Zhen, CPA as independent accountant on August 1, 2024.
Two directors resign; CFO William Sluss appointed to Bio Essence Board
Yangyang Huang and Simon Shavanson resigned from Board on June 12, 2024; no material dispute.
Bio Essence Corp. sells subsidiary Bio Essence Herbal Essentials to Health Up Inc. for $400k
Sold wholly-owned subsidiary Bio Essence Herbal Essentials Inc. (BEP) to Health Up Inc. for $400,000 cash.
Bio Essence sells subsidiary BEP for $300K; director Sharon Mair resigns
Sold wholly owned subsidiary Bio Essence Pharmaceutical to Newways, Inc. for $300,000 cash; close expected by Dec 31, 2023.
On June 12, 2024, Yangyang Huang and Simon Shavanson (collectively the “Resigning Directors”) resigned from the Board of Directors of Bio Essence Corp. (the “Company”).
On June 18, 2024, the Company’s remaining directors unanimously appointed William Sluss to the Board of Directors pursuant to Article II, Section 6 of the Company’s Bylaws.
On June 12, 2024, Yangyang Huang and Simon Shavanson (collectively the “Resigning Directors”) resigned from the Board of Directors of Bio Essence Corp. (the “Company”).
On December 8, 2023, the Company received notice from Sharon Mair, a member of the Company’s Board of Directors, that she resigned from the Board of Directors effective immediately.
Max materiality 0.75 · Median 0.50 · Most common event m_and_a